Psychosocial predictors of non-adherence to chronic medication: Systematic review of longitudinal studies

Patient Preference and Adherence

Volumn 8, Issue , 2014, Pages 519-563

  Zwikker, Hanneke E ^a   van den Bemt, Bart J ^a,b   Vriezekolk, Johanna E ^a   van den Ende, Cornelia H ^a   van Dulmen, Sandra ^b,c,d  

^a Sint Maartenskliniek   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c NETHERLANDS INSTITUTE FOR HEALTH SERVICES RESEARCH   (Netherlands)

^d UNIVERSITY OF SOUTH EASTERN NORWAY   (Norway)

Author keywords

Longitudinal studies; Medication adherence; Psychosocial factors; Somatic and chronic diseases; Systematic review

Indexed keywords

CHARACTER STATE; COGNITION; COPING BEHAVIOR; DISEASE DURATION; EMOTIONALITY; HEALTH BELIEF; LOCUS OF CONTROL; LONGITUDINAL STUDY; MENTAL STRESS; PSYCHOLOGICAL WELL BEING; PSYCHOSOCIAL CARE; QUALITATIVE ANALYSIS; REVIEW; SENSITIVITY ANALYSIS; SOCIAL ASPECT; SOCIAL INFLUENCE; SOCIAL SUPPORT; SYSTEMATIC REVIEW; TASK PERFORMANCE; TREATMENT REFUSAL;

EID: 84899654079     PISSN: None     EISSN: 1177889X     Source Type: Journal    
DOI: 10.2147/PPA.S47290     Document Type: Review

References (78)

1. ABC project team. Ascertaining barriers for compliance: policies for save, effective and cost-effective use of medicines in Europe. Final report of the ABC-Project. Lodz, Poland: ABC Project; 2012. Available from: http://abcproject.eu/index.php?page=publications. Accessed September 14, 2012.
2. World Health Organization. Adherence to long-term therapies. Evidence for action. Geneva: World Health Organization; 2003. Available from: http://whqlibdoc.who.int/publications/2003/9241545992.pdf. Accessed August 1, 2012.
3. van Dulmen S, Sluijs E, van Dijk L, de Ridder D, Heerdink R, Bensing J. Patient adherence to medical treatment: a review of reviews. BMC Health Serv Res. 2007; 7:55.
4. Psaty BM, Koepsell TD, Wagner EH, LoGerfo J P, Inui TS. The relative risk of incident coronary heart disease associated with recently stopping the use of beta-blockers. JAMA. 1990; 263(12):1653-1657.
5. Balkrishnan R, Christensen DB. Inhaled corticosteroid use and associated outcomes in elderly patients with moderate to severe chronic pulmonary disease. Clin Ther. 2000; 22(4):452-469.
6. Elliott RA. Poor adherence to medication in adults with rheumatoid arthritis: reasons and solutions. Dis Manag Health Outcome. 2008; 16(1):13-29.
7. Gauchet A, Tarquinio C, Fischer G. Psychosocial predictors of medication adherence among persons living with HIV. Int J Behav Med. 2007; 14(3):141-150.
8. Gremigni P, Bacchi F, Turrini C, Cappelli G, Albertazzi A, Bitti PE. Psychological factors associated with medication adherence following renal transplantation. Clin Transplant. 2007; 21(6):710-715.
9. Horne R, Weinman J. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res. 1999; 47(6):555-567.
10. Kane S V, Robinson A. Review article: understanding adherence to medication in ulcerative colitis - innovative thinking and evolving concepts. Aliment Pharmacol Ther. 2010; 32(9):1051-1058.
11. Morrison V, Fargher E, Parveen, S et al. Determinants of Patient Adherence to Antihypertensive Medication: A Multi-national Cross-sectional Study. Lodz, Poland: ABC Project; 2012. Available from: http://abcproject.eu/index.php?page=publications. Accessed July 10, 2013.
12. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005; 353(5):487-497.
13. Unni E, Farris KB. Determinants of different types of medication non-adherence in cholesterol lowering and asthma maintenance medications: a theoretical approach. Patient Educ Couns. 2011; 83(3):382-390.
14. Haynes RB, Ackloo E, Sahota N, McDonald H P, Ya o X. Interventions for enhancing medication adherence [review]. Cochrane Database Syst Rev. 2008; 2:CD000011.
15. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009; 339:b2700.
16. http://www.cbs.nl [homepage on the Internet]. Defnitions. Someone with a Western background. Centraal Bureau voor de Statistiek; 2012. Available from: http://www.cbs.nl/en-GB/menu/methoden/begrippen/default.htm?Languageswitch=on&ConceptID=1057. Accessed November 11, 2012.
17. Osamor PE, Owumi BE. Factors associated with treatment compliance in hypertension in southwest Nigeria. J Health Popul Nutr. 2011; 29(6):619-628.
18. Martikainen P, Bartley M, Lahelma E. Psychosocial determinants of health in social epidemiology. Int J Epidemiol. 2002; 31(6):1091-1093.
19. Holmes WC, Bilker WB, Wang H, Chapman J, Gross R. HIV/AIDS-specifc quality of life and adherence to antiretroviral therapy over time. J Acquir Immune Defc Syndr. 2007; 46(3):323-327.
20. Kuo YF, Raji MA, Markides KS, Ray LA, Espino DV, Goodwin JS. Inconsistent use of diabetes medications, diabetes complications, and mortality in older mexican americans over a 7-year period: data from the Hispanic established population for the epidemiologic study of the elderly. Diabetes Care. 2003; 26(11):3054-3060.
21. Mizuno R, Fujimoto S, Uesugi A, et al. Infuence of living style and situation on the compliance of taking antihypertensive agents in patients with essential hypertension. Intern Med. 2008; 47(19):1655-1661.
22. Murri R, Ammassari A, De Luca A, et al. Self-reported nonadherence with antiretroviral drugs predicts persistent condition. HIV Clin Trials. 2001; 2(4):323-329.
23. Elamin MB, Flynn DN, Bassler D, et al. Choice of data extraction tools for systematic reviews depends on resources and review complexity. J Clin Epidemiol. 2009; 62(5):506-510.
24. Zaza S, Wright-De Agüero LK, Briss PA, et al. Data collection instrument and procedure for systematic reviews in the Guide to Community Preventive Services. Task Force on Community Preventive Services. Am J Prev Med. 2000; 18(Suppl 1):44-74.
25. Deschamps AE, Graeve VD, van Wijngaerden E, et al. Prevalence and correlates of nonadherence to antiretroviral therapy in a population of HIV patients using Medication Event Monitoring System. AIDS Patient Care STDS. 2004; 18(11):644-657.
26. Nabi H, Vahtera J, Singh-Manoux A, et al. Do psychological attributes matter for adherence to antihypertensive medication? The Finnish Public Sector Cohort Study. J Hypertens. 2008; 26(11):2236-2243.
27. Hayden JA, Côté P, Bombardier C. Evaluation of the quality of prognosis studies in systematic reviews. Ann Intern Med. 2006; 144(6): 427-437.
28. de Vet HC, Mokkink LB, Terwee CB, Hoekstra OS, Knol DL. Clinicians are right not to like Cohen's κ. BMJ. 2013; 346:f2125.
29. Streiner DL, Norman GR. Health Measurement Scales: A Practical Guide to Their Development and Use. 4th ed. New York: Oxford University Press; 2008.
30. Verbeek J, Ruotsalainen J, Hoving JL. Synthesizing study results in a systematic review. Scand J Work Environ Health. 2012; 38(3):282-290.
31. Newman S, Mulligan K. The psychology of rheumatic diseases. Baillieres Best Pract Res Clin Rheumatol. 2000; 14(4):773-786.
32. Ogden J. Health Psychology: A Textbook. 3rd ed. England: Open University Press; 2004.
33. Ponieman D, Wisnivesky J P, Leventhal H, Musumeci-Szabó TJ, Halm EA. Impact of positive and negative beliefs about inhaled corti-costeroids on adherence in inner-city asthmatic patients. Ann Allergy Asthma Immunol. 2009; 103(1):38-42.
34. Venturini F, Nichol MB, Sung JC, Bailey KL, Cody M, McCombs JS. Compliance with sulfonylureas in a health maintenance organization: a pharmacy record-based study. Ann Pharmacother. 1999; 33(3): 281-288.
35. Gazmararian JA, Kripalani S, Miller MJ, Echt K V, Ren J, Rask K. Factors associated with medication refll adherence in cardiovascular-related diseases: a focus on health literacy. J Gen Intern Med. 2006; 21(12):1215-1221.
36. Grégoire J, Moisan J, Guibert R, Ciampi A, Milot A. Predictors of self-reported noncompliance with antihypertensive drug treatment: a prospective cohort study. Can J Cardiol. 2006; 22(4):323-329.
37. Miller P, Wikoff RL, McMahon M, Garrett MJ, Ringel K. Indicators of medical regimen adherence for myocardial infarction patients. Nurs Res. 1985; 34(5):268-272.
38. Molloy GJ, Perkins-Porras L, Bhattacharyya MR, Strike PC, Steptoe A. Practical support predicts medication adherence and attendance at cardiac rehabilitation following acute coronary syndrome. J Psychosom Res. 2008; 65(6):581-586.
39. Delgado J, Heath K V, Yip B, et al. Highly active antiretroviral therapy: physician experience and enhanced adherence to prescription refll. Anti-vir Ther. 2003; 8(5):471-478.
40. Singh N, Squier C, Sivek C, Wagener M, Nguyen MH, Yu VL. Determinants of compliance with antiretroviral therapy in patients with human immunodefciency virus: prospective assessment with implications for enhancing compliance. AIDS Care. 1996; 8(3):261-269.
41. Singh N, Berman SM, Swindells S, et al. Adherence of human immu-nodefciency virus-infected patients to antiretroviral therapy. Clin Infect Dis. 1999; 29(4):824-830.
42. Bottonari KA, Roberts JE, Ciesla JA, Hewitt RG. Life stress and adherence to antiretroviral therapy among HIV-positive individuals: a preliminary investigation. AIDS Patient Care STDS. 2005; 19(11): 719-727.
43. Godin G, Côté J, Naccache H, Lambert LD, Trottier S. Prediction of adherence to antiretroviral therapy: a one-year longitudinal study. AIDS Care. 2005; 17(4):493-504.
44. Kacanek D, Jacobson DL, Spiegelman D, Wanke C, Isaac R, Wilson IB. Incident depression symptoms are associated with poorer HAART adherence: a longitudinal analysis from the Nutrition for Healthy Living study. J Acquir Immune Defc Syndr. 2010; 53(2): 266-272.
45. Martini M, D'Elia S, Paoletti F, et al. Adherence to HIV treatment: results from a 1-year follow-up study. HIV Med. 2002; 3(1):62-64.
46. Mellins CA, Kang E, Leu CS, Havens JF, Chesney MA. Longitudinal study of mental health and psychosocial predictors of medical treatment adherence in mothers living with HIV disease. AIDS Patient Care STDS. 2003; 17(8):407-416.
47. Nilsson Schönnesson L, Diamond PM, Ross M W, Williams M, Bratt G. Baseline predictors of three types of antiretroviral therapy (ART) adherence: A 2-year follow-up. AIDS Care. 2006; 18(4): 407-414.
48. Thrasher AD, Earp JA, Golin CE, Zimmer CR. Discrimination, distrust, and racial/ethnic disparities in antiretroviral therapy adherence among a national sample of HIV-infected patients. J Acquir Immune Defc Syndr. 2008; 49(1):84-93.
49. Horne R, Cooper V, Gellaitry G, Date HL, Fisher M. Patients' perceptions of highly active antiretroviral therapy in relation to treatment uptake and adherence: the utility of the necessity-concerns framework. J Acquir Immune Defc Syndr. 2007; 45(3):334-341.
50. Mugavero MJ, Raper JL, Reif S, et al. Overload: impact of incident stressful events on antiretroviral medication adherence and virologic failure in a longitudinal, multisite human immunodefciency virus cohort study. Psychosom Med. 2009; 71(9):920-926.
51. Carrieri M P, Leport C, Protopopescu C, et al. Factors associated with nonadherence to highly active antiretroviral therapy: a 5-year follow-up analysis with correction for the bias induced by missing data in the treatment maintenance phase. J Acquir Immune Defic Syndr. 2006; 41(4):477-485.
52. Stilley CS, DiMartini AF, de Vera ME, et al. Individual and environmental correlates and predictors of early adherence and outcomes after liver transplantation. Prog Transplant. 2010; 20(1):58-66; quiz 67.
53. De Geest S, Abraham I, Moons P, et al. Late acute rejection and sub-clinical noncompliance with cyclosporine therapy in heart transplant recipients. J Heart Lung Transplant. 1998; 17(9):854-863.
54. Russell CL, Cetingok M, Hamburger KQ, et al. Medication adherence in older renal transplant recipients. Clin Nurs Res. 2010; 19(2): 95-112.
55. Weng FL, Israni AK, Joffe MM, et al. Race and electronically measured adherence to immunosuppressive medications after deceased donor renal transplantation. J Am Soc Nephrol. 2005; 16(6):1839-1848.
56. Dew MA, Roth LH, Thompson ME, Kormos RL, Griffth B P. Medical compliance and its predictors in the frst year after heart transplantation. J Heart Lung Transplant. 1996; 15(6):631-645.
57. Dew MA, Dimartini A F, De Vito Dabbs A, et al. Adherence to the medical regimen during the frst two years after lung transplantation. Transplantation. 2008; 85(2):193-202.
58. Dobbels F, Vanhaecke J, Dupont L, et al. Pretransplant predictors of posttransplant adherence and clinical outcome: an evidence base for pretransplant psychosocial screening. Transplantation. 2009; 87(10):1497-1504.
59. DiMatteo MR, Sherbourne CD, Hays RD, et al. Physicians' characteristics infuence patients' adherence to medical treatment: results from the Medical Outcomes Study. Health Psychol. 1993; 12(2):93-102.
60. Hoogendoorn WE, van Poppel MN, Bongers PM, Koes BW, Bouter LM. Systematic review of psychosocial factors at work and private life as risk factors for back pain. Spine (Phila Pa 1976). 2000; 25(16):2114-2125.
61. Proper KI, Singh AS, van Mechelen W, Chinapaw MJ. Sedentary behaviors and health outcomes among adults: a systematic review of prospective studies. Am J Prev Med. 2011; 40(2):174-182.
62. Vriezekolk JE, van Lankveld WG, Geenen R, van den Ende CH. Longitudinal association between coping and psychological distress in rheumatoid arthritis: a systematic review. Ann Rheum Dis. 2011; 70(7):1243-1250.
63. Wrześniewski K, Włodarczyk D. Sense of coherence as a personality predictor of the quality of life in men and women after myocardial infarction. Kardiol Pol. 2012; 70(2):157-163.
64. Cholowski K, Cantwell R. Predictors of medication compliance among older heart failure patients. Int J Older People Nurs. 2007; 2(4): 250-262.
65. Ediger J P, Walker JR, Graff L, et al. Predictors of medication adherence in infammatory bowel disease. Am J Gastroenterol. 2007; 102(7): 1417-1426.
66. Frazier PA, Davis-Ali SH, Dahl KE. Correlates of noncompliance among renal transplant recipients. Clin Transplant. 1994; 8(6):550-557.
67. Holt E W, Muntner P, Joyce C, Morisky DE, Webber LS, Krousel-Wood M. Life events, coping, and antihypertensive medication adherence among older adults: the cohort study of medication adherence among older adults. Am J Epidemiol. 2012; 176 Suppl 7:S64-S71.
68. Smalls BL, Walker RJ, Hernandez-Tejada MA, Campbell JA, Davis KS, Egede LE. Associations between coping, diabetes knowledge, medication adherence and self-care behaviors in adults with type 2 diabetes. Gen Hosp Psychiatry. 2012; 34(4):385-389.
69. Bailey CJ, Kodack M. Patient adherence to medication requirements for therapy of type 2 diabetes. Int J Clin Pract. 2011; 65(3): 314-322.
70. Hawthorne AB, Rubin G, Ghosh S. Review article: medication non-adherence in ulcerative colitis - strategies to improve adherence with mesalazine and other maintenance therapies. Aliment Pharmacol Ther. 2008; 27(12):1157-1166.
71. Jackson CA, Clatworthy J, Robinson A, Horne R. Factors associated with non-adherence to oral medication for infammatory bowel disease: a systematic review. Am J Gastroenterol. 2010; 105(3):525-539.
72. Odegard PS, Capoccia K. Medication taking and diabetes: a systematic review of the literature. Diabetes Educ. 2007; 33(6):1014-1029; discussion 1030-1031.
73. van den Bemt BJ, Zwikker HE, van den Ende CH. Medication adherence in patients with rheumatoid arthritis: a critical appraisal of the existing literature. Expert Rev Clin Immunol. 2012; 8(4):337-351.
74. Wu JR, Moser DK, Lennie TA, Burkhart P V. Medication adherence in patients who have heart failure: a review of the literature. Nurs Clin North Am. 2008; 43(1):133-153; vii.
75. Ammassari A, Trotta M P, Murri R, et al; AdICoNA Study Group. Correlates and predictors of adherence to highly active antiretroviral therapy: overview of published literature. J Acquir Immune Defc Syndr. 2002; 31 Suppl 3:S123-S127.
76. Restrepo RD, Alvarez MT, Wittnebel LD, et al. Medication adherence issues in patients treated for COPD. Int J Chron Obstruct Pulmon Dis. 2008; 3(3):371-384.
77. Slavin RE. Best evidence synthesis: an intelligent alternative to meta-analysis. J Clin Epidemiol. 1995; 48(1):9-18.
78. Overman CL, Bossema ER, van Middendorp H, et al. The prospective association between psychological distress and disease activity in rheumatoid arthritis: a multilevel regression analysis. Ann Rheum Dis. 2012; 71(2):192-197.